雙星新材(002585.SZ):二億平米光學膜暨五十萬噸高功能膜項目一期30萬噸高功能性聚酯膜材料項目全部投運
格隆匯12月17日丨雙星新材(002585.SZ)公佈,公司為進一步延伸光學材料產業鏈,加速“五大板塊”新材料成長,投資建設“二億平米光學膜暨五十萬噸高功能膜項目”。目前一期的“30萬噸高功能性聚酯膜材料項目”年內6條產線已陸續全部安裝調試完畢,並全面投運。該項目達產後,公司光學材料及高功能膜產品產能將有較大幅度的提高,有利於進一步優化結構,持續加快新產品的開發應用,有利於進一步提高市場份額及市場競爭力,項目的投產將對公司的未來發展帶來積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.